Case Report

Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host

Published: February 14, 2014
Genet. Mol. Res. 13 (4) : 9308-9314 DOI: https://doi.org/10.4238/2014.February.14.8
Cite this Article:
W.X. Qu, X.W. Feng, L. Zhao (2014). Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host. Genet. Mol. Res. 13(4): 9308-9314. https://doi.org/10.4238/2014.February.14.8
982 views

Abstract

Immunocompromised individuals are susceptible to pulmonary Aspergillus infections, whereas invasive Aspergillus infection is extremely rare in the presence of normal immunity. A case of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent 57-year-old female host who was successfully treated with amphotericin-B and voriconazole is reported here.

Immunocompromised individuals are susceptible to pulmonary Aspergillus infections, whereas invasive Aspergillus infection is extremely rare in the presence of normal immunity. A case of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent 57-year-old female host who was successfully treated with amphotericin-B and voriconazole is reported here.

About the Authors